Related by context. All words. (Click for frequent words.) 69 adrenergic agonists 67 adrenergic agonist 66 beta3 66 adrenoreceptor 64 adrenergic agonists LABAs 64 1 proteinase inhibitor 63 1 antitrypsin AAT 62 agonist LABA 61 adrenergic receptor agonist 61 adrenoceptor agonist 61 beta1 60 alpha1 proteinase inhibitor 60 Tumor Necrosis Factor 60 integrin alpha 60 adrenoceptor 60 adrenergic receptor 60 anticholinergic agents 59 Adrenergic 59 Epoetin 59 2A receptor agonist 59 anti trypsin deficiency 58 HLA DR4 58 receptor blocker 58 Interferon Alfa 58 venlafaxine Effexor 58 abacavir Ziagen 57 1 Antitrypsin AAT 57 Idiopathic Pulmonary Fibrosis 57 SGPT 57 imipramine Tofranil 57 ara C 57 Catenin 57 Orally administered 57 adrenergic receptors 57 reuptake inhibitor 57 Atomoxetine 57 beta interferons 57 Exacerbation 57 selective phosphodiesterase 56 GH deficiency 56 1 Antitrypsin 56 5HT 56 antiepileptics 56 insulin glulisine 56 Nilotinib 56 quetiapine Seroquel 56 receptor blockers 56 HCV Genotype 56 Allergic Rhinitis 56 hypophosphatemia 56 beta 1a 56 clomipramine 56 Fabrazyme ® agalsidase 56 μmol L 56 therapeutic peptide Thymosin 56 aripiprazole Abilify 55 2 microglobulin 55 Receptor Antagonists 55 interferon IFN 55 uricase 55 PEGylated anti 55 Pharmacologic 55 tacrolimus ointment 55 methimazole 55 LPS induced 55 Parnate 55 tricyclic antidepressants TCAs 55 interleukin IL 55 TNF Tumor Necrosis Factor 55 Bosentan 55 Adjunctive 55 pegylated IFN 55 guanfacine extended release 55 Myelodysplastic Syndrome MDS 55 1 Antitrypsin Deficiency 55 SPRYCEL ® 55 prolactin elevation 54 warfarin sodium 54 AChE inhibitors 54 INVEGA ® 54 A1PI 54 glulisine 54 Platinol ® 54 Decitabine 54 receptor antagonists 54 GHRH 54 Bronchiectasis 54 alpha1 antitrypsin deficiency 54 glucans 54 Reductase 54 TNF IL 54 Secondary Hyperparathyroidism 54 metastatic malignant 54 1 antitrypsin 54 methylphenidate Ritalin 54 Angiotensin Converting Enzyme 54 dual endothelin receptor antagonist 54 Diabetic Neuropathy 54 congenital deficiency 54 Chronic Myelogenous Leukemia 54 leukemia AML 54 Xyfid TM 54 Chemotherapy induced 54 bullous 54 Ecallantide 54 Fingolimod 54 selective agonists 54 mu opioid 54 Beta1 54 beta2 54 CLINICAL PHARMACOLOGY 54 metastatic neuroendocrine tumors 54 somatostatin analog 54 International Prognostic Scoring 54 Chemokine Receptor 54 norepinephrine reuptake inhibitor SNRI 54 Relapsing remitting 54 Interferon Beta 54 1 Proteinase Inhibitor 54 Prolongs Survival 54 Adenosine A2A 54 antitrypsin 54 Generalized Anxiety Disorder 54 treat chronic sinusitis 54 Cryopyrin Associated Periodic Syndromes 53 Mg Usa 53 complement inhibitor eculizumab 53 Atopic Dermatitis 53 Parathyroid Hormone 53 systemic juvenile idiopathic 53 N methyl 53 Pharmacokinetics PK 53 anticholinergics 53 anemias 53 Erythropoietic 53 IFN beta 53 Ziprasidone 53 5 HT2A 53 Mg Uk 53 norepinephrine reuptake inhibitor 53 visilizumab 53 topical calcineurin inhibitors 53 beta hydroxy 53 Secretase 53 PsA 53 selective modulator 53 thrombocytosis 53 Genotypes 53 CIMZIA R 53 bronchial hyperresponsiveness 53 Haloperidol 53 Valproic acid 53 Protease Inhibitors 53 sensory neuropathy 53 Pegylated Liposomal Doxorubicin 53 2 Microglobulin beta 53 insulin secretagogues 53 See CLINICAL PHARMACOLOGY 53 gamma glutamyl 53 RISPERDAL ® 53 juvenile idiopathic arthritis JIA 53 Tricyclic antidepressants 53 desipramine 53 interstitial fibrosis 53 Clinical Practice Guideline 53 Macrophage 53 antidepressants SSRIs 53 Supplemental Figure 53 Chronic Sinusitis 53 Rivastigmine 53 Papillary 53 creatine kinase CK 53 topical gel formulation 53 DMSA 53 Methylphenidate 53 Elevated serum 53 Bosutinib 53 Dehydrogenase 53 serotonin reuptake inhibitor 53 Shows Statistically Significant 53 CIAS1 53 % CI #.#-#.# [007] 53 Long acting beta2 53 Non Alcoholic Steatohepatitis 53 selective antagonist 52 fluoropyrimidine 52 monocyte chemotactic protein 52 Adjunctive Therapy 52 demyelinating 52 SGOT 52 Carbaglu 52 unconjugated 52 SSRI citalopram 52 headache abdominal pain 52 Impaired glucose tolerance 52 selective adenosine 52 Natalizumab 52 NNT = 52 triiodothyronine 52 pouchitis 52 Agonists 52 Transgenic Mice 52 alpha1 52 reflux disease GERD 52 Improves Outcomes 52 rilonacept 52 dasatinib Sprycel 52 induce orthostatic hypotension 52 ,#,# [002] 52 haemolytic 52 Pgp 52 carbidopa 52 Recombinant Human 52 Cannabinoid 52 bile acid sequestrant 52 ipratropium bromide 52 LAB CGRP 52 Tumour Necrosis Factor 52 thiopurine 52 relapsing multiple sclerosis 52 Blepharospasm 52 GW# [003] 52 adrenocorticotropic hormone 52 Teriflunomide 52 Plaquenil 52 Allogeneic 52 idiopathic thrombocytopenic purpura 52 arginine vasopressin AVP 52 Showed Significant 52 humanized monoclonal 52 CYP#D# inhibitor 52 TPMT 52 recurrent epithelial ovarian 52 prazosin 52 Endocarditis 52 oral prednisolone 52 NK1 52 AVONEX ® 52 vWD 52 prostaglandin E 52 beta hydroxy acids 52 pheochromocytoma 52 Escitalopram 52 Beta Amyloid 52 cisplatin chemotherapy 52 somatostatin 52 selectively inhibited 52 hyperhomocysteinemia 52 mg p = 52 Antiviral Therapy 52 deoxy 52 Fatty Liver 52 Systemic Juvenile Idiopathic 52 hemolytic 52 intratympanic 52 integrin alpha 4 52 selective agonist 52 ACEI 52 Chemotherapy Induced 52 IFN α 52 Tubulin 52 Cervical Dystonia 52 muscarinic 52 5 hydroxytryptamine 52 Novel Compound 52 alpha2 52 Lymphocytic 51 Î ² 51 Heterozygous Familial Hypercholesterolemia 51 HuMax 51 Hypercholesterolemia 51 torsade de pointes 51 mitoxantrone chemotherapy 51 fluticasone propionate FP 51 Relapsing Remitting Multiple Sclerosis 51 paroxetine sertraline 51 Lymphoid 51 fluconazole resistant 51 Subclinical 51 Heritability 51 Severity Scale 51 Irritable Bowel 51 bronchoalveolar lavage 51 purpura ITP 51 Actinic Keratosis 51 denileukin diftitox 51 Myelofibrosis 51 murine model 51 hypereosinophilic syndrome 51 Spasticity 51 interleukin 1ß 51 collagenous colitis 51 lymphocytic leukemia 51 lysosomal storage disease 51 radioimmunoassay 51 atrophic gastritis 51 GG genotype 51 immune thrombocytopenic purpura 51 transcranial Doppler ultrasound 51 crohn disease 51 Follicular Lymphoma 51 CLL SLL 51 Neupro R 51 post transplant lymphoproliferative 51 Stomatitis 51 Iron Deficiency Anemia 51 Cardiotoxicity 51 Squamous 51 Risk Stratification 51 Antipsychotic 51 Hemolytic 51 icatibant 51 Cellular Immunotherapy 51 beta HSD1 51 primary aldosteronism 51 Selective serotonin reuptake inhibitors 51 myeloproliferative diseases 51 glutamyl 51 Diabetic Nephropathy 51 Phase IIa Clinical Trial 51 D glucan 51 chills fever headache 51 myelodysplastic myeloproliferative diseases 51 Zoloft sertraline 51 risperidone Risperdal 51 Novantrone 51 Peripheral Arterial 51 Hypertrophic 51 Subtypes 51 Ascites 51 Receptor Agonist 51 Gastritis 51 T2DM 51 transaminases 51 endothelin receptor 51 carcinoid tumors 51 Hyperkalemia 51 Conjugate 51 Janus Kinase 51 glucosidase 51 cardiac conduction 51 pregabalin Lyrica 51 Glatiramer acetate 51 Chronic Insomnia 51 induced colitis 51 bradykinin 51 NS#/#A protease 51 peptide CGRP 51 Sinemet 51 Phase 2b Trial 51 parkinsonian 51 adrenergic 51 Polyneuropathy 51 Comorbidities 51 chronic eosinophilic leukemia 51 lansoprazole Prevacid 51 Familial Cold Auto 51 del 5q 51 Fungal Infections 51 5alpha reductase 51 polymyalgia rheumatica 51 Orthostatic Hypotension 51 Aurora Kinase 51 Geodon ziprasidone 51 demonstrated antitumor activity 51 alpha antagonist 51 Partial Response 51 Rheumatoid 51 Idiopathic 51 Achieves Primary Endpoint 51 kallikrein 51 μg ml 51 keto 51 donepezil Aricept 51 Subtype 51 diphosphate 51 Attention-Deficit/Hyperactivity Disorder ADHD 51 #HT# 51 mitochondrial toxicity 51 hyperparathyroidism 51 thrombin receptor 51 NQO1 51 Geographic Atrophy 51 bupropion Wellbutrin 51 nonsevere 51 ancrod 50 exendin 4 50 thyrotropin 50 cytopenia 50 ACE Inhibitor 50 Enzastaurin 50 nicotinic 50 RezularTM 50 HT 1A 50 enterococcal 50 Diabetic Patients 50 acyl CoA 50 Common Toxicity Criteria 50 Randomized Phase 50 Phosphorylation 50 psoriatic arthritis PsA 50 methoxy 50 rheumatoid arthritis inflammatory bowel 50 Paliperidone 50 mediated inhibition 50 Refractory Hodgkin Lymphoma 50 irreversible inhibitor 50 PEGylated Fab fragment 50 Modulates 50 guanfacine 50 TNFalpha 50 GlcNAc 50 IL 1ß 50 Nonalcoholic Fatty Liver Disease 50 Novel Inhibitor 50 gamma aminobutyric acid 50 Tyrosine Kinase Inhibitor 50 Temsirolimus 50 diabetes mellitus DM 50 PAOD 50 Lewy Bodies 50 quinoline 50 AGILECT ® 50 Tyrosine Kinase 50 1beta 50 danazol 50 Plaque Psoriasis 50 medullary thyroid carcinoma 50 Myelodysplastic Syndrome 50 Adenomas 50 Synthase 50 comorbid anxiety 50 agonists 50 glycogen synthase kinase 50 mGluR2 NAM 50 Leukotriene 50 nicotinic acetylcholine 50 null mice 50 p# mitogen activated 50 isoprostane 50 leukopenia pancytopenia thrombocytopenia 50 fibulin 50 neuroleptic 50 idiopathic PAH 50 psychostimulants 50 Intravenous immunoglobulin 50 Thrombocytopenia 50 multisystemic 50 N acetyl 50 Shows Promise Against 50 Major Depressive Disorder MDD 50 hyaluronidase enzyme 50 acute intermittent porphyria 50 pegylated 50 humanized interleukin 6 50 TNF receptor 50 Asthma COPD 50 Estrogen Receptor 50 Ala Ala 50 Protease 50 Biogen Idec Avonex 50 disulfiram 50 Severe Primary IGFD 50 headache vomiting 50 Synuclein 50 novel VDA molecule 50 NSTEMI 50 Systemic Sclerosis 50 nicotinic acetylcholine receptor 50 Glomerular 50 isoenzyme 50 epithelial tumors 50 Leukemias 50 Atypical Antipsychotic 50 Polymorphisms 50 Thrombotic 50 Phase Ib Clinical Trial 50 intranasal corticosteroids 50 electroacupuncture 50 Sertraline 50 Savella TM 50 Enzyme Replacement Therapy 50 chronic idiopathic thrombocytopenic purpura 50 Neurogenic 50 Hcy 50 T1DM 50 ADPKD 50 Systemic Lupus Erythematosus 50 Antiplatelet 50 inhaled corticosteroid therapy 50 idiopathic generalized epilepsy 50 idiopathic Parkinson disease 50 Granulomatous 50 lichen planus 50 glatiramer acetate 50 severe malignant osteopetrosis 50 TNF alpha IL 50 MGd 50 Omacetaxine 50 von Willebrand Factor 50 recurrent sinusitis 50 alpha TNF 50 C1 INH deficiency 50 LTRA 50 gamma agonists 50 Community Acquired Pneumonia 50 small molecule tyrosine 50 Respiratory Syncytial Virus 50 homozygotes 50 IGFBP 50 Non Alcoholic Fatty 50 Gleevec resistant 50 CYP#A# substrate 50 hyperprolactinemia 50 Hepatic Encephalopathy 50 Janus kinase 50 Degenerative Disc Disease 50 Integrase Inhibitor 50 Kinase Inhibitors 50 AAT deficiency 50 tumor xenograft models 50 Acute Myeloid Leukaemia AML 50 vinorelbine tartrate 50 tricalcium phosphate 50 spirometric 50 thyrotoxicosis 50 phosphatidylserine PS 50 Idiopathic Thrombocytopenic Purpura ITP 50 Symptom Severity 50 Hyperlipidemia 50 Chronic HCV 50 Investigational Oral 50 β thalassemia 50 Cell Function 50 trans retinoic acid 50 Dyspnea 50 murine models 50 Anti Tumor 50 Interferon gamma 50 cheilitis 50 2A agonist 50 sodium glucose cotransporter 50 Cutaneous 50 urticaria hives 50 Bacteremia 50 ANCA associated 50 pravastatin Pravachol 50 p# MAP kinase inhibitor 50 somatostatin analogue 50 Histone Deacetylase 49 IDDM 49 fosbretabulin 49 XYZAL 49 ® lenalidomide 49 JAK2 V#F 49 immunomodulatory therapy 49 aripiprazole 49 promoter polymorphism 49 Growth Hormone Deficiency 49 Differential diagnosis 49 Glycosylation 49 Orally Active 49 cystic fibrosis chronic pancreatitis 49 Omalizumab 49 serotonin norepinephrine reuptake inhibitor 49 Mozilla Firefox #.#.# 49 serotonin receptor 49 CD4 + lymphocytes 49 intermittent dosing 49 integrin receptor 49 Adverse Event 49 Suicidality 49 Ischemic 49 LV dysfunction 49 venlafaxine XR 49 anticholinergic medication 49 Myalgia 49 leukotriene receptor antagonists 49 Progenitor Cells 49 diabetic gastroparesis 49 Oral Fingolimod 49 #ß 49 CTAP# Capsules 49 Polymorphism 49 duloxetine hydrochloride 49 plasminogen activator inhibitor 49 polycythemia vera essential thrombocythemia 49 Protease Inhibitor 49 Critical Limb Ischemia CLI 49 mg/# mL [001] 49 CTEPH 49 Janssen Risperdal 49 advanced neuroendocrine tumors 49 cell adhesion molecule 49 airway hyperresponsiveness 49 hyperlipidemia hypertension 49 Symptom severity 49 Subgroup analysis 49 Panic Disorder 49 Reduces Mortality 49 Immune Responses 49 Nucleoside 49 estradiol E2 49 Risperidone 49 NYHA 49 histological subtype 49 Topoisomerase II 49 docetaxel pretreated 49 Factor VIIa 49 Signaling Pathway 49 Unstable Angina 49 Henoch purpura 49 MKC# 49 Pivotal Phase 49 antiphospholipid syndrome 49 treat benign prostatic 49 5 HT1A 49 diabetes dyslipidemia 49 PYY #-# 49 Efficacy Trial 49 gastrointestinal dysfunction 49 benign prostatic hypertrophy BPH 49 PLA2 49 cyclin dependent kinase inhibitor 49 SSAO 49 Protein Kinase C 49 CC genotype 49 KSP inhibitors 49 Streptococcus pyogenes 49 Aortic stenosis 49 Beta2 49 synthetic analogues 49 Angioedema 49 Abilify aripiprazole 49 apolipoprotein B 49 Exacerbations 49 Mouse Model 49 p# alpha [001] 49 Potent Anti 49 myofascial pain syndrome 49 Tumor necrosis factor 49 Diagnostic Criteria 49 Symptom Scale 49 Chronic Heart Failure 49 Hypertensive Patients 49 5 HT1A receptor 49 receptor tyrosine kinase inhibitor 49 Patients Treated With 49 TNF Blockers 49 Fibroblast 49 Soft Tissue Sarcoma 49 Alemtuzumab 49 Denufosol 49 aggressive systemic mastocytosis 49 rhIGF-I/rhIGFBP-3 49 Riluzole 49 extrapyramidal symptoms 49 Commonly prescribed 49 Paxil paroxetine 49 Progressive Multifocal Leukoencephalopathy 49 primary dysmenorrhea 49 rheumatoid arthritis osteoarthritis ankylosing 49 Initiates Clinical Trial 49 inducible nitric oxide synthase 49 Telintra 49 erythematosus 49 regression coefficient 49 Newly Diagnosed Multiple Myeloma 49 Interferon beta 49 neurological manifestations 49 Thymic 49 liposomal formulation 49 receptor monoclonal antibody 49 administered concomitantly 49 Sjogren Syndrome 49 Systemic Lupus Erythematosus SLE 49 Clinical Outcome 49 Roflumilast 49 Inflammatory bowel diseases 49 SSc 49 Predict Response 49 Combo Therapy 49 C#BL 6 mice 49 Unresectable 49 Hsp# Inhibitor 49 Acne Vulgaris 49 NAGS deficiency 49 CRF antagonists 49 PEG Interferon 49 tegaserod 49 systemic amyloidosis 49 C Reactive Protein 49 subependymal giant cell 49 erlotinib Tarceva 48 Polycythemia Vera 48 Hypertriglyceridemia 48 nociceptive pain 48 Fibrinogen 48 Double Blind Randomized 48 Interferon beta 1a 48 intercellular adhesion molecule 48 daytime somnolence 48 Juvenile Idiopathic Arthritis JIA 48 Nephrogenic 48 PathHunter 48 TÎ ² 4 48 Primary Pulmonary Hypertension 48 patientswith 48 Upregulation 48 autosomal recessive genetic 48 ADHD stimulant 48 adrenal hormone 48 teriflunomide 48 comorbid depression 48 Pramlintide 48 alemtuzumab Campath 48 Lipoprotein 48 dipeptidyl peptidase 4 48 Comorbid 48 CP CPPS 48 atypical neuroleptics 48 serotonin norepinephrine 48 Chronic Renal Failure 48 Systemic lupus erythematosus SLE 48 Avandia Actos 48 AT1 receptor 48 Generalized Anxiety Disorder GAD 48 fluvastatin Lescol 48 desmopressin 48 Gorlin syndrome 48 Galectin 48 Psychiatric Disorders 48 Rilonacept 48 IL 1beta 48 tuberous sclerosis TS 48 Androgen Receptor 48 PEGylated interferon 48 acting injectable formulation 48 Paroxysmal 48 cytogenetic abnormalities 48 Arcalyst 48 cyclic nucleotide 48 cytidine 48 Incretin 48 Prostaglandin 48 Novel Oral 48 neovascular 48 Chronic lymphocytic leukemia 48 interleukin IL -# 48 juvenile idiopathic arthritis 48 varenicline Chantix 48 Glioblastoma Multiforme GBM 48 myeloid metaplasia 48 Shows Efficacy 48 xanthine 48 INCB# [003] 48 Respiratory Virus 48 chemokine receptors 48 thrombotic thrombocytopenic purpura 48 gene polymorphism 48 Myopathy 48 inflammatory cytokines TNF 48 microsomes 48 montelukast Singulair 48 Chronic Fatigue Syndrome CFS 48 tricyclic anti depressants 48 HepDirect prodrug 48 sensory gating 48 bronchogenic carcinoma 48 adverse cytogenetics 48 Acute Renal Failure 48 Etanercept 48 Complicated Skin 48 Inhibitory 48 Symptom Checklist 48 Albuferon TM 48 Ribavirin causes 48 Tumor Response 48 2M Transferrin Tfr 48 basal cell carcinoma BCC 48 Main Outcome Measure 48 Phase 2b Clinical Trial 48 VIIBRYD 48 ® lisdexamfetamine dimesylate 48 cortisol synthesis 48 insomnia somnolence 48 Streptococcus agalactiae 48 48 Functional Dyspepsia 48 alpha TNF α 48 Inhibits 48 Atopic 48 HuMax HepC 48 neuroendocrine cancers 48 pharmacologic treatments 48 HLA A2 48 Respiratory Syncytial Virus RSV 48 myoclonus 48 Estrogen receptor 48 #:#-# [031] 48 Peginterferon Alfa 2a 48 basal bolus regimen 48 receptor antagonism 48 Myelodysplastic Syndromes 48 Eslicarbazepine acetate 48 Essential Tremor 48 Cytochrome P# 48 BXT # 48 Malignant Glioma 48 newer atypical antipsychotics 48 Bucindolol 48 colorectal carcinoma 48 Isomer 48 myasthenia gravis MG 48 von Willebrand Disease 48 lymphoma subtypes 48 antiepileptic medications 48 ABCB1 48 Multiple Myeloma MM 48 Mutational 48 glucan 48 Epitopes 48 Malignancies 48 Lenalidomide 48 nicotinic receptor 48 baroreceptor 48 interpersonal psychotherapy IPT 48 diabetic kidney 48 myeloperoxidase 48 Neuropathic 48 rufinamide 48 isolated systolic hypertension 48 Chronic Inflammatory 48 Epirubicin 48 1 antitrypsin deficiency 48 raloxifene Evista 48 ropinirole Requip 48 prostaglandin E2 PGE2 48 Bruton tyrosine kinase 48 Monoclonal Antibody 48 Glycoprotein 48 cyclooxygenase COX 48 SOM# 48 Glioblastoma Multiforme 48 Nasacort AQ 48 Acute Decompensated Heart Failure 48 Acute Bacterial Sinusitis ABS 48 Pregabalin 48 HLA DRB1 * 48 induced phosphorylation 48 acute myeloid 48 Raptiva efalizumab 48 HeFH 48 Appears Safe 48 pathophysiological effects 48 GLP 1R 48 Imatinib mesylate 48 osteosarcomas 48 constipation predominant IBS 48 thymoma 48 Tß4 48 5 HT3 antagonist 48 CD4 + CD# 48 Alequel 48 Neuroprotection 48 Inhaled Corticosteroids 48 Diffuse Large B 48 Y BOCS 48 FAMPYRA 48 Immunotherapeutic 48 transthyretin TTR mediated amyloidosis 48 Angiotensin converting enzyme 48 histone deacetylase HDAC inhibitor 48 Cyclooxygenase 48 parkinson disease 48 malignant lymphoma 48 epithelial sodium 48 cTnI 48 Roche MabThera 48 Initiate Phase 48 Oncolytic 48 phosphoprotein 48 encephalopathies 48 Plus Ribavirin 48 oral anticoagulation therapy 48 infliximab etanercept 48 Oxymorphone ER 48 syncope fainting 47 Alkyl 47 Screenshot Tour 47 MELAS 47 metaplasia 47 lymphomas leukemias 47 Pain Rating Scale 47 Antipsychotics 47 Gln 47 IgG4 47 CONCERTA ® 47 Equetro 47 Prosaptide 47 monocytic 47 Kinase Inhibitor 47 Begins Dosing 47 cholecystokinin CCK 47 ß2 47 novel orally bioavailable 47 Phase IIA 47 K. pneumoniae 47 Bronchial Asthma 47 kidney insufficiency 47 Seroquel quetiapine 47 Aripiprazole 47 fluoxetine Prozac 47 xeroderma pigmentosum 47 PRN FDA Approves 47 CYT# potent vascular disrupting 47 ND# [002] 47 Major Depressive Disorder 47 antisense inhibitor 47 tiagabine 47 kappa B 47 alpha4 47 MGUS 47 Microalbuminuria 47 Enbrel Humira 47 Iodide 47 Epidermal Growth Factor Receptor 47 Virus Infection 47 AT1R 47 cytokine interleukin 47 alpha TNFa 47 TLR antagonist 47 R flurbiprofen 47 imatinib Gleevec ® 47 Tardive Dyskinesia 47 Focalin XR 47 oral antidiabetics 47 Zollinger Ellison syndrome 47 beta 47 Relapsed Refractory 47 1alpha 47 Adrenal 47 adenosine A2A 47 R lenalidomide 47 axonal damage 47 Latuda 47 Buffer Overflow Vulnerability 47 pDC 47 constitutively active 47 pulmonary hypertension PH 47 Acute Coronary Syndromes ACS 47 5 HT2A inverse 47 treatment naive genotype 47 Cymbalta duloxetine 47 Initiated Phase 47 nucleotide analog 47 experimental autoimmune encephalomyelitis 47 primary Restless Legs 47 Norepinephrine 47 Abatacept 47 Oxidative 47 microsatellite instability 47 reversible inhibitor 47 Metadate 47 Partial Seizures 47 systemic fungal infections 47 PKC# 47 Initiates Clinical 47 cardiomyopathy weakening 47 Integrin 47 Iron Overload 47 Betaferon Betaseron 47 Package Insert 47 TTR amyloidosis 47 divalent 47 INVEGA ™ 47 mastocytosis 47 neoplasias 47 Tesmilifene 47 pramipexole Mirapex 47 amnestic 47 Differentially 47 Impaired Glucose Tolerance 47 Keratitis 47 AA Amyloidosis 47 FDG PET imaging 47 immunocompetent 47 lupus erythematosus 47 cytomegalovirus infection 47 ABCG1 47 dipeptide 47 hypothalamic pituitary 47 secretagogue 47 Intuniv 47 proliferator activated receptor 47 B Cell Lymphoma 47 neurologic disorder 47 cutaneous melanoma 47 alpha pinene